CYP3A4 and COVID-19: IL-6, a good biomarker to test severe cases of COVID-19 [71], plays a pivotal role in the downregulation [108] of CYP (especially CYP1A, CYP3A, CYP2C9, and CYP2C19) and CES1 (Table 2).